Stock listing

NASDAQ:SBBP Strongbridge Biopharma PLC Stock

Follow Strongbridge Biopharma PLC into a list and get an email when it puts out news.

Last close · NASDAQ:SBBP

$2.00 USD

Close on Oct 5, 2021 · No longer trades

Oct 16, 2015 to last close -80.1% · weekly closes, Oct 16, 2015 – Oct 5, 2021
Lowest – highest close
$1.47 – $10.05 USDSince Oct 16, 2015 · lowest Nov 18, 2019 · highest Oct 16, 2015

Delisted NASDAQ:SBBP no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:SBBP
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Strongbridge Biopharma PLC on 6ix

Decks
6 decks · latest May 24, 2021

Decks

DeckKindSlidesDate
Merger or Acquisition (May 2021)Merger or acquisition22 slidesMay 24, 2021
Investor Presentation (September 2020)Investor deck42 slidesSep 8, 2020
Shareholder Meeting (April 2020)Shareholder meeting9 slidesApr 20, 2020
Investor Presentation (February 2020)Investor deck42 slidesFeb 25, 2020
Investor Presentation (November 2019)Investor deck29 slidesNov 19, 2019
Q2 2018 Earnings PresentationEarnings33 slidesAug 8, 2018

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
John H. Johnson
Other companies: Xeris Biopharma Holdings, Inc. (Independent, Non-executive Board Member · Since at least Oct 5, 2021); Axogen, Inc. (Director · Since at least Jul 19, 2021); Verastem, Inc. (Director · Since at least Apr 23, 2020); Applied Therapeutics Inc (Executive Chairman, Director · Dec 19, 2024 – Dec 19, 2024 · Past); Melinta Therapeutics Inc (Chief Executive Officer, Director · Jun 12, 2018 – Jun 27, 2019 · Past); AVEO Pharmaceuticals Inc (Director · Feb 1, 2018 – Feb 1, 2018 · Past); Cempra Inc (Director · Jan 3, 2017 – Jan 3, 2017 · Past); Ocugen, Inc. (Director · Dec 16, 2016 – Jun 15, 2018 · Past); Portola Pharmaceuticals Inc (Director · Jun 17, 2016 – Jul 2, 2020 · Past); Sucampo Pharmaceuticals Inc (Director · Jun 2, 2016 – Feb 13, 2018 · Past)
Chief Executive Officer, Director · Jan 1, 2018 – Oct 5, 2021 · Past
David Gill
Other companies: Telix Pharmaceuticals Limited (Chair & Independent Non-Executive Director · Since at least May 11, 2026); Y mAbs Therapeutics (Director · Since at least Sep 20, 2018); Evolus, Inc. Common Stock (Director · Since at least Feb 12, 2018); STRATA Skin Sciences, Inc. (Director · May 30, 2018 – Nov 22, 2019 · Past); Melinta Therapeutics Inc (Director · May 25, 2018 – Jun 11, 2019 · Past); Ocugen, Inc. (Director · Dec 9, 2016 – Jun 15, 2018 · Past); Cempra Inc (Director · Jan 1, 2016 – Jan 3, 2017 · Past); EndoChoice Holdings Inc (President and CFO · Aug 14, 2015 – Nov 22, 2016 · Past)
Director · Sep 3, 2019 – Oct 5, 2021 · Past
Matt Pauls
Other companies: Palvella Therapeutics, Inc. (Director · Since at least Jun 29, 2026); Pelthos Therapeutics Inc. (Director · Since at least Jul 1, 2025); Soleno Therapeutics, Inc. (Director · Since at least Aug 15, 2023); Savara, Inc. (CHIEF EXECUTIVE OFFICER, Director · Since at least Oct 29, 2015); Egalet Corporation (Director · Jan 31, 2019 – May 20, 2020 · Past)
President & CEO, Director · Jan 1, 2018 – Feb 20, 2019 · Past
Garheng Kong
Other companies: Xeris Biopharma Holdings, Inc. (Director · Since at least Oct 5, 2021); Labcorp Holdings Inc. (Director · Since at least Feb 4, 2020); Venus Concept Inc (Director · Nov 7, 2019 – Mar 24, 2023 · Past); Alimera Sciences Inc (Director · Jun 19, 2019 – Jan 4, 2023 · Past)
Director · May 15, 2019 – Oct 5, 2021 · Past
Marten Steen
Other companies: Ultragenyx Pharmaceutical Inc. (Director · Jan 30, 2014 – Jan 30, 2014 · Past)
Director · Jan 1, 2018 – Oct 5, 2021 · Past
Fredric J CohenChief Medical Officer · Jan 1, 2018 – Oct 5, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about Strongbridge Biopharma PLC.